GNVR Genvor Inc
Agricultural Production-Crops · OTC · SEC CIK 1792941 · Fiscal year ends 09/30
Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY41.0%
TTM EPS YoY62.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-1,611.2%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets969.3%
Debt / equity—
Current ratio0.09x
Interest coverage-37.14x
Cash quality & payout
Operating cash flow / net income0.31x
Accruals ratio-1,119.1%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-06-30 | 2026Q22026-03-31 | 2026Q12025-12-31 | 2025Q4*2025-09-30 | 2025Q32025-06-30 | 2025Q22025-03-31 | 2025Q12024-12-31 | 2024Q4*2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | — | — | — | — | — | — | — | — |
| R&D expense | $205,977 | $57,228 | $57,147 | $65,849 | $271,816 | $54,812 | $63,424 | $33,352 |
| Operating income | -$2.48M | -$407,492 | -$562,655 | -$558,838 | -$577,543 | -$276,056 | -$5.00M | -$158,738 |
| Interest expense | $61,703 | $14,318 | $15,025 | $16,910 | $16,138 | $22,927 | $3,837 | $861 |
| Pretax income | -$2.56M | -$429,567 | -$576,280 | $108,972 | -$397,779 | -$298,983 | -$5.00M | -$159,599 |
| Net income | -$2.56M | -$429,567 | -$576,280 | $108,972 | -$397,779 | -$298,983 | -$5.00M | -$159,599 |
| EBITDA | — | — | — | -$558,837 | -$577,084 | -$275,598 | -$5.00M | -$158,281 |
| EPS (basic) | -0.07 | — | -0.02 | — | -0.01 | -0.01 | -0.24 | — |
| EPS (diluted) | -0.07 | -0.01 | -0.02 | — | -0.01 | -0.01 | -0.24 | — |
| Weighted avg. shares (diluted) | 36.08M | 33.90M | 32.76M | — | 27.47M | 24.90M | 20.67M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $196,522 | $94,808 | $103,580 | $37,231 | $98,933 | $641 | $581 | $373 |
| Current assets | $262,243 | $176,762 | $145,739 | $45,822 | $103,894 | $8,055 | $12,605 | $21,678 |
| PP&E, net | — | — | — | — | $12,528 | $12,986 | $13,444 | $13,902 |
| Total assets | $312,243 | $176,762 | $145,739 | $45,822 | $116,422 | $21,041 | $26,049 | $35,580 |
| Current liabilities | $2.81M | $1.07M | $1.21M | $1.36M | $1.71M | $2.10M | $1.87M | $1.75M |
| Long-term debt | — | — | — | $20,000 | — | — | — | $904,508 |
| Total debt | — | — | — | $20,000 | — | — | — | $904,508 |
| Total liabilities | $3.03M | $1.07M | $1.21M | $1.36M | $1.71M | $2.10M | $1.87M | $1.75M |
| Shareholders' equity | -$2.71M | -$891,095 | -$1.06M | -$1.31M | -$1.60M | -$2.08M | -$1.84M | -$1.71M |
| Net debt | — | — | — | -$17,231 | — | — | — | $904,135 |
| Shares outstanding | 36.41M | 35.95M | 34.43M | 30.18M | 29.75M | 24.90M | 24.90M | 20.03M |
| Cash flow statement | ||||||||
| Operating cash flow | -$304,744 | -$400,562 | -$193,651 | -$155,778 | -$327,364 | -$71,133 | -$1,442 | -$19,768 |
| Financing cash flow | $406,458 | $391,790 | $260,000 | $94,076 | $425,656 | $71,193 | $1,650 | $20,000 |
| Depreciation & amortization | — | — | — | $1 | $459 | $458 | $458 | $457 |
| Stock-based compensation | $116,700 | $105,000 | $125,000 | $67,500 | $62,500 | $62,500 | $4.74M | $0 |
Free plan shows the latest 8 periods; Pro shows all 30 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.